Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Aging is associated with hyporesponse to vaccination, whose mechanisms remain unclear. In this study hepatitis B virus (HBV)-naive older adults received three vaccines, including one against HBV. Here we show, using transcriptional and cytometric profiling of whole blood collected before vaccination, that heightened expression of genes that augment B-cell responses and higher memory B-cell frequencies correlate with stronger responses to HBV vaccine. In contrast, higher levels of inflammatory response transcripts and increased frequencies of pro-inflammatory innate cells correlate with weaker responses to this vaccine. Increased numbers of erythrocytes and the haem-induced response also correlate with poor response to the HBV vaccine. A transcriptomics-based pre-vaccination predictor of response to HBV vaccine is built and validated in distinct sets of older adults. This moderately accurate (area under the curve≈65%) but robust signature is supported by flow cytometry and cytokine profiling. This study is the first that identifies baseline predictors and mechanisms of response to the HBV vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCI can also impair normal immune function, leading to increased susceptibility to infections and tumors and a poor response to vaccines22–25.”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This may help explain why mediators of systemic chronic inflammation have been linked to suboptimal vaccine responses in not only the elderly26,27 but in younger individuals as well28.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“previous reports showing that high levels of baseline inflammatory markers correlate with weaker responses to hepatitis B and herpes zoster vaccine formulations15,91.”
From An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging (2021) · cites this paper as [91]
In the citing paper
“Elevated SCI has also been shown to predict hyporesponsiveness to the hepatitis B vaccine in humans24”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Estimating the Number of Clusters in a Data Set Via the Gap Statistic
Tibshirani, R., Walther, G., & Hastie, T. (2001) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00293 · Cited by 6,205
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
MAQC Consortium (2010) · Nature Biotechnology · doi:10.1038/nbt.1665 · Cited by 889
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.001 · Cited by 610
Sayed, N., Huang, Y., Nguyen, K., Krejciova-Rajaniemi, Z., Grawe, A. P., Gao, T., Tibshirani, R., Hastie, T., Alpert, A., Cui, L., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00082-y · Cited by 572
SARS-CoV-2, COVID-19 and the aging immune system
Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359
The science and medicine of human immunology
Pulendran, B., & Davis, M. M. (2020) · Science · doi:10.1126/science.aay4014 · Cited by 274
Personalized vaccinology: A review
Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.07.062 · Cited by 196
“This signature, including serum cytokine profiling and flow cytometric correlates of response, predicted the antibody response to HBV with up to 65% accuracy [78].”
Kotliarov, Y., Sparks, R., Martins, A. J., Mulè, M. P., Lu, Y., Goswami, M., Kardava, L., Banchereau, R., Pascual, V., Biancotto, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0769-8 · Cited by 190
Human immune diversity: from evolution to modernity
Liston, A., Humblet-Baron, S., Duffy, D., & Goris, A. (2021) · Nature Immunology · doi:10.1038/s41590-021-01058-1 · Cited by 187
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
Pereira, B., Xu, X.-N., & Akbar, A. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583019 · Cited by 178
BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner
Koeken, V. A. C. M., de Bree, L. C. J., Mourits, V. P., Moorlag, S. J. C. F. M., Walk, J., Cirovic, B., Arts, R. J. W., Jaeger, M., Dijkstra, H., Lemmers, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133935 · Cited by 164
“Our data are partially in line with previous observations that lower prevaccination inflammation enhances vaccine immunogenicity (28, 29), which in our case holds specifically true for induction of innate immune memory responses in males.”
BackgroundResultHagan, T., Gerritsen, B., Tomalin, L. E., Fourati, S., Mulè, M. P., Chawla, D. G., Rychkov, D., Henrich, E., Miller, H. E. R., Diray‐Arce, J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01328-6 · Cited by 173
Self-citationPan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination
Fourati, S., Tomalin, L. E., Mulè, M. P., Chawla, D. G., Gerritsen, B., Rychkov, D., Henrich, E., Miller, H. E. R., Hagan, T., Diray‐Arce, J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01329-5 · Cited by 173
“In contrast, pre-vaccination expression of genes related to granulocytes and interferon-stimulated genes (ISGs) have been associated with a poor response to hepatitis B vaccination 6,12 .”
InfluentialSelf-citationImproving Vaccine-Induced Immunity: Can Baseline Predict Outcome?
Tsang, J. S., Dobaño, C., Damme, P. V., Moncunill, G., Marchant, A., Othman, R. B., Sadarangani, M., Koff, W. C., & Kollmann, T. R. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.001 · Cited by 146
“Specifically, in adults aged ≥65 years, higher expression of inflammatory response transcripts and increased frequencies of proinflammatory innate immune cells in peripheral blood correlate with lower anti-HBs antibody responses [11].”
Immunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Wagner, A., & Weinberger, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00717 · Cited by 119
“Inflammatory responses and augmented B cell responses before vaccination were moderately accurate predictors of poor or stronger responses of older adults to Hepatitis B vaccination, respectively (229).”
BackgroundComplex immune correlates of protection in HIV ‐1 vaccine efficacy trials
Tomaras, G. D., & Plotkin, S. A. (2017) · Immunological Reviews · doi:10.1111/imr.12514 · Cited by 127
Vukmanovic-Stejic, M., Chambers, E. S., Suárez-Fariñas, M., Sandhu, D., Fuentes-Duculan, J., Patel, N., Agius, E., Lacy, K. E., Turner, C. T., Larbi, A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.032 · Cited by 103
Chambers, E. S., Vukmanovic-Stejic, M., Shih, B. B., Trahair, H., Subramanian, P., Devine, O. P., Glanville, J., Gilroy, D., Rustin, M. H. A., Freeman, T. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-020-00010-6 · Cited by 96
Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
Izmirly, A. M., Alturki, S. O., Alturki, S. O., Connors, J. R., & Haddad, E. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01055 · Cited by 92
“Researchers in 2015 reported that the pre-vaccination inflammation and blunted B cell signaling due to aging correlates with the hyporesponse to the hepatitis B (HBV) vaccination (70).”
BackgroundFighting against a protean enemy: immunosenescence, vaccines, and healthy aging
Del Giudice, G., Goronzy, J. J., Grubeck-Loebenstein, B., Lambert, P.-H., Mrkvan, T., Stoddard, J. J., & Doherty, T. M. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0020-0 · Cited by 91
Vaccination as a preventative measure contributing to immune fitness
Laupèze, B., Giudice, G. D., Doherty, M. T., & der Most, R. G. V. (2021) · npj Vaccines · doi:10.1038/s41541-021-00354-z · Cited by 109
Immunological factors linked to geographical variation in vaccine responses
van Dorst, M. M. A. R., Pyuza, J. J., Nkurunungi, G., Kullaya, V. I., Smits, H. H., Hogendoorn, P. C. W., Wammes, L. J., Everts, B., Elliott, A. M., Jochems, S. P., et al. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00941-2 · Cited by 90
“In elderly individuals, age-related alterations, such as lifelong exposure to immunological triggers and reduced ability of immune cell self-renewal, result in smaller naive T and B cell pools, which along with low-grade sterile inflammation, can underlie poor responses to vaccines 48,49 .”
Systems vaccinology and big data in the vaccine development chain
Raeven, R. H. M., van Riet, E., Meiring, H. D., Metz, B., & Kersten, G. F. A. (2018) · Immunology · doi:10.1111/imm.13012 · Cited by 84
Jin, J., Mu, Y., Zhang, H., Sturmlechner, I., Wang, C., Jadhav, R. R., Xia, Q., Weyand, C. M., & Goronzy, J. J. (2023) · Nature Aging · doi:10.1038/s43587-023-00399-w · Cited by 76
Immunosenescence and inflamm-ageing in COVID-19
Zinatizadeh, M. R., Zarandi, P. K., Ghiasi, M., Kooshki, H., Mohammadi, M., Amani, J., & Rezaei, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101818 · Cited by 77
A roadmap towards personalized immunology
Delhalle, S., Bode, S. F. N., Balling, R., Ollert, M. W., & HeFeng, F. Q. (2018) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0045-9 · Cited by 78
“Through a transcriptomics analysis, Fourati and coauthors identified an age-related signature and a 15-gene signature predictive of vaccine hypo-responsiveness to hepatitis B virus surface antigen in naïve older adults.(41) Possibly due to the fact that the transcriptomic analysis was based on whole blood samples, the…”
BackgroundZhang, T., Androulakis, I. P., Bonate, P., Cheng, L., Helikar, T., Parikh, J., Rackauckas, C., Subramanian, K., Cho, C. R., on behalf of the Working Group, et al. (2022) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-022-09805-z · Cited by 62
“Vaccine hyporesponse in the elderly is associated with chronic inflammation and has been studied using multilayer molecular profiling in order to identify mechanisms to target for therapeutic discovery [87].”
BackgroundCortese, M., Hagan, T., Rouphael, N., Wu, S.-Y., Xie, X., Kazmin, D. A., Wimmers, F., Gupta, S., der Most, R. G. V., Coccia, M., et al. (2025) · Nature Immunology · doi:10.1038/s41590-024-02036-z · Cited by 78
“…a comprehensive analysis of the cellular and molecular networks driving immune response to vaccination and has defined molecular signatures that predict antibody response to vaccination with the yellow fever, seasonal influenza and other vaccines 11–16 , revealing new mechanistic insights 17–19 .”
Sebina, I., & Pepper, M. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.02.001 · Cited by 73
How aging impacts vaccine efficacy: known molecular and cellular mechanisms and future directions
Chen, J., Deng, J. C., & Goldstein, D. R. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.09.008 · Cited by 64
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Borgognone, A., Noguera-Julián, M., Oriol-Tordera, B., Noël‐Romas, L., Ruiz‐Riol, M., Guillén, Y., Parera, M., Casadellà, M., Duran-Castells, C., Puertas, M. C., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01247-6 · Cited by 66
Soegiarto, G., Wulandari, L., Purnomosari, D., Fahmita, K. D., Gautama, H. I., Hadmoko, S. T., Prasetyo, M. E., Mahdi, B. A., Arafah, N., Prasetyaningtyas, D., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.05.059 · Cited by 66
“In conditions with chronic systemic inflammation, there are considerable alterations in all tissues and organs that may affect normal cell functions, including the immune response to vaccines [40,41].”
BackgroundPredictive Markers of Immunogenicity and Efficacy for Human Vaccines
Tilbeurgh, M. V., Lemdani, K., Beignon, A., Chapon, C., Tchitchek, N., Cheraitia, L., López, E. M., Pascal, Q., Grand, R. L., Maisonnasse, P., et al. (2021) · Vaccines · doi:10.3390/vaccines9060579 · Cited by 74
“Although systems vaccinology approaches have already been used in human cohorts of aged individuals [63,221,222], high-throughput characterization of vaccine-induced responses in children are still rare [9,223] and awaited for newborns [224].”
BackgroundParadoxical aging in HIV: immune senescence of B Cells is most prominent in young age
Rinaldi, S., Pallikkuth, S., George, V. K., de Armas, L. R., Pahwa, R., Sanchez, C. M., Pallin, M. F., Pan, L., Cotugno, N., Dickinson, G., et al. (2017) · Aging · doi:10.18632/aging.101229 · Cited by 56
“A study by our group in a small cohort of post-menopausal HIV+ and HIV negative women concluded that aging worsens response to flu vaccines and another detailed review of HBV responses also made the conclusion that impairment of vaccine responses were greater in HIV+ than age-matched aging healthy volunteers [28].”
BackgroundImmunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Fülöp, T., Larbi, A., Pawelec, G., Cohen, A. A., Provost, G., Khalil, A., Lacombe, G., Rodrigues, S., Desroches, M., Hirokawa, K., et al. (2022) · Vaccines · doi:10.3390/vaccines10040607 · Cited by 61
Tsukamoto, H., Kouwaki, T., & Oshiumi, H. (2020) · iScience · doi:10.1016/j.isci.2020.101520 · Cited by 62
Bartholomeus, E., Neuter, N. D., Meysman, P., Suls, A., Keersmaekers, N., Elias, G., Jansens, H., Hens, N., Smits, E., Tendeloo, V. F. V., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.09.001 · Cited by 49
Rosenberg, B. R., Depla, M., Freije, C. A., Gaucher, D., Mazouz, S., Boisvert, M., Bédard, N., Bruneau, J., Rice, C. M., & Shoukry, N. H. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007290 · Cited by 49
“virus (HBV) vaccines [14] have underscored the role of baseline inflammation and host factors in determining the outcome of vaccination.”
BackgroundHung, H., Tsai, S., Chou, H., Tsai, M., Hsu, P., & Kuo, Y.-M. (2023) · Scientific Reports · doi:10.1038/s41598-023-32710-5 · Cited by 54
Lee, E. E., Song, K., Hwang, W., Ham, S. Y., Jeong, H., Kim, J. H., Oh, H. S., Kang, Y. M., Lee, E. B., Kim, N. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87668-z · Cited by 47
Tomalka, J. A., Suthar, M. S., Deeks, S. G., & Sékaly, R. (2022) · Nature Immunology · doi:10.1038/s41590-022-01130-4 · Cited by 47
Self-citationTransition Metal‐Based Therapies for Inflammatory Diseases
Song, Y., You, Q., & Chen, X. S. (2023) · Advanced Materials · doi:10.1002/adma.202212102 · Cited by 50
Weinberger, B., Haks, M. C., de Paus, R. A., Ottenhoff, T. H. M., Bauer, T., & Grubeck‐Loebenstein, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01035 · Cited by 43
Mulè, M. P., Martins, A. J., Cheung, F., Farmer, R., Sellers, B. A., Quiel, J. A., Jain, A., Kotliarov, Y., Bansal, N., Chen, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.009 · Cited by 48
Correlates of malaria vaccine efficacy
Stanisic, D. I., & McCall, M. B. B. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1882309 · Cited by 39
Shannon, C. P., Blimkie, T. M., Ben-Othman, R., Gladish, N., Amenyogbe, N., Drissler, S., Edgar, R. D., Chan, Q. W. T., Krajden, M., Foster, L. J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578801 · Cited by 38
COVID-19 and Down syndrome: the spark in the fuel
Majithia, M., & Ribeiro, S. P. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00745-w · Cited by 34
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Chen, J., Vitetta, L., Henson, J. D., & Hall, S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104850 · Cited by 32
“Fourati et al. (2016) found that pre-vaccination inflammation was associated with hyporesponse to HepB vaccination (Fourati et al., 2016).”
Moncunill, G., Mpina, M., Nhabomba, A. J., Aguilar, R., Ayestaran, A., Sanz, H., Campo, J. J., Jairoce, C., Barrios, D., Dong, Y., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix429 · Cited by 33
Omersel, J., & Kuželički, N. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113561 · Cited by 34
“The concept that certain HLA and HLA-associated alleles and haplotypes might predispose for nonresponse and autoimmunity after HBV vaccination is in part confirmed by a recent whole-genome transcriptomic study that showed that HBV vaccine non-responders had higher pre-vaccination expression levels of pro-inflammatory…”
ResultThe Immune Signatures data resource, a compendium of systems vaccinology datasets
Diray‐Arce, J., Miller, H. E. R., Henrich, E., Gerritsen, B., Mulè, M. P., Fourati, S., Gygi, J. P., Hagan, T., Tomalin, L. E., Rychkov, D., et al. (2022) · Scientific Data · doi:10.1038/s41597-022-01714-7 · Cited by 38
Self-citationRisk Factors for Long COVID in Older Adults
Hu, Y., Liu, Y., Zheng, H., & Liu, L. (2023) · Biomedicines · doi:10.3390/biomedicines11113002 · Cited by 42
Weinberg, A., Pang, L., Johnson, M. J., Caldas, Y. A., Cho, A., Tovar-Salazar, A., Canniff, J. D., Schmader, K. E., Popmihajlov, Z., & Levin, M. J. (2019) · Journal of Virology · doi:10.1128/jvi.00305-19 · Cited by 32
“Chronologically older adults form a heterogeneous group with respect to biological age, and previous studies have shown more robust correlations of vaccine responses with biological rather than chronological age in older adults (19).”
ResultRaven, S. F. H., Hoebe, C. J. P. A., Vossen, A. C. T. M., Visser, L. G., Hautvast, J. L. A., Roukens, A. H. E., & van Steenbergen, J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30417-7 · Cited by 32
An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly
Bell, M. R., & Kutzler, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114175 · Cited by 29
Lingblom, C., Kowli, S., Swaminathan, N., Maecker, H. T., & Lambert, S. L. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1528-1 · Cited by 31
“Higher levels of inflammatory response transcripts have been linked with hypo responsiveness to hepatitis B vaccination [29].”
BackgroundVaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice
Arévalo, M. T., Huang, Y., Jones, C. A., & Ross, T. M. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007316 · Cited by 25
Innate antiviral immunity: how prior exposures can guide future responses
Tomalka, J. A., Suthar, M. S., Diamond, M., & Sékaly, R. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.07.001 · Cited by 29
Self-citationBallester, M. P., Jalan, R., & Mehta, G. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100776 · Cited by 29
Bissa, M., Kim, S., Galli, V., Fourati, S., Sarkis, S., Arakelyan, A., de Castro, I. S., Rahman, M. A., Fujiwara, S., Vaccari, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36109-8 · Cited by 27
Self-citationSystems Human Immunology and AI: Immune Setpoint and Immune Health
Lei, Y., & Tsang, J. S. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-042631 · Cited by 31
Paramithiotis, E., Sugden, S., Papp, E., Bonhomme, M., Chermak, T., Crawford, S. Y., Demetriades, S. Z., Galdos, G., Lambert, B. L., Mattison, J. E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880784 · Cited by 26
Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping Review
Bello, N., Hudu, S. A., Alshrari, A. S., Imam, M. U., & Jimoh, A. O. (2024) · Pathogens · doi:10.3390/pathogens13070554 · Cited by 29
“Moreover, the differentiation of B cells into memory cells and plasma cells that produce high-affinity antibodies is also mediated by T follicular helper cells (Tfh) through a reaction at the germinal centre.”
BackgroundIdoko, O. T., Smolen, K. K., Wariri, O., Imam, A., Shannon, C. P., Dibbasey, T., Diray‐Arce, J., Darboe, A., Strandmark, J., Ben-Othman, R., et al. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00197 · Cited by 23
“Similar reasoning regarding HepB vaccine as a model for systems biology have led to deciphering of mechanisms relevant for the immune response in older adults (26).”
BackgroundBaseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS
Nehar-Belaid, D., Sokolowski, M. J., Ravichandran, S., Banchereau, J., Chaussabel, D., & Ucar, D. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101842 · Cited by 20
Orekhov, A. N., Summerhill, V. I., Khotina, V. A., Popov, M. A., Uzokov, J., & Sukhorukov, V. N. (2023) · Gene Expression · doi:10.14218/ge.2023.00061 · Cited by 37
“49 In addition, chronic inflammation during pregnancy and childhood can have severe developmental implications that include increasing the risk of chronic inflammatory conditions over the life span.”
BackgroundVaccine innovations for emerging infectious diseases—a symposium report
Cable, J., Srikantiah, P., Crowe, J. E., Pulendran, B., Hill, A. V. S., Ginsberg, A. M., Koff, W. C., Mathew, A., Ng, T. W., Jansen, K. U., et al. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14235 · Cited by 24
Wooden, S. L., & Koff, W. C. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1476813 · Cited by 19
Swaminathan, G., Citron, M. P., Xiao, J., Norton, J. E., Reens, A. L., Topçuoğlu, B. D., Maritz, J. M., Lee, K.-J., Freed, D. C., Weber, T. M., et al. (2021) · Vaccines · doi:10.3390/vaccines9111340 · Cited by 19
Moncunill, G., Carnes, J., Young, W. C., Carpp, L. N., Rosa, S. C. D., Campo, J. J., Nhabomba, A. J., Mpina, M., Jairoce, C., Finak, G., et al. (2021) · eLife · doi:10.7554/elife.70393 · Cited by 16
Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
Ford, B. N., & Savitz, J. B. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00288-7 · Cited by 19
Hirota, M., Tamai, M., Yukawa, S., Taira, N., Matthews, M. M., Toma, T., Seto, Y., Yoshida, M., Toguchi, S., Miyagi, M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04755-9 · Cited by 20
Understanding immune variation for improved translational medicine
Duffy, D. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.06.005 · Cited by 18
Scanlon, N., Saklawi, Y., & Rouphael, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582201 · Cited by 18
Memory and CAR‐NK cell‐based novel approaches for HIV vaccination and eradication
Mazarzaei, A., Vafaei, M., Ghasemian, A., Mirforughi, S. A., Rajabi-Vardanjani, H., & Alwan, N. A. S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28280 · Cited by 18
“…have been performed with the introduction of the Universal Vaccine Signature in response to various vaccine candidates for the efficacy of the vaccine and specific genes related to effective response to diseases such as yellow fever and hepatitis B (Fourati et al., 2016; Muyanja et al., 2014).”
BackgroundLeal, L., Fehér, C., Richart, V., Torres, B., & García, F. (2020) · Vaccines · doi:10.3390/vaccines8030442 · Cited by 16
“Both of these studies underline the importance of the predominance of specific immune response in order to achieve better response to vaccination, similar to what was observed by others in the case of different preventive vaccines [77,79] including one for HIV-1 [82].”
ResultTowards Predicting Protective Vaccine Responses in the Very Young
Kollmann, T. R., & Marchant, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.05.005 · Cited by 18
Shafqat, A., Masters, M. C., Tripathi, U., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102400 · Cited by 15
López‐Gatell, H., García‐García, L., Echániz-Avilés, G., Cruz‐Hervert, L. P., Olamendi-Portugal, M., Castaneda, D., Sánchez-Alemán, M. Á., Martínez, M. R., DeAntonio, R., Cervantes-Apolinar, M. Y., et al. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1533617 · Cited by 15
“0 mIU/ ml.(20,21) Therefore, seroprevalence derived from vaccination may have been underestimated.”
BackgroundImmune Aging, Immunosenescence, and Inflammaging: Implications for Vaccine Response in Older Adults
Falahi, S., Abdoli, A., & Kenarkoohi, A. (2025) · Health Science Reports · doi:10.1002/hsr2.71119 · Cited by 22
“Findings showed that poor responses to the vaccine were associated with higher frequencies of pro ‐ inflammatory innate cells and higher levels of transcripts of inflammation ‐ related genes [36].”
Maeyer, R. P. H. D., Sikora, J., Bracken, O. V., Shih, B. B.-J., Lloyd, A. F., Peckham, H., Hollett, K., Abdelhamid, K., Cai, W., James, M., et al. (2025) · Aging Cell · doi:10.1111/acel.70249 · Cited by 21
“Inflammageing is a phenomenon whereby circulating inflammatory mediators such as C Reactive protein (CRP), IL-6, and IL-8 (Ferrucci and Fabbri 2018) increase during ageing.”
Older Human B Cells and Antibodies
Dunn‐Walters, D. K., & O’Hare, J. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_21-1 · Cited by 19
Manchanda, V., Mitra, S., Rafique, I., Sharma, A., Dhakad, M. S., Saxena, S., Kapoor, S., & Kumar, S. (2022) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2023.100391 · Cited by 12
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Purcell, R. A., Theisen, R. M., Arnold, K. B., Chung, A. W., & Selva, K. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183727 · Cited by 18
Acute and persistent responses after H5N1 vaccination in humans
Apps, R., Biancotto, A., Candia, J., Kotliarov, Y., Perl, S., Cheung, F., Farmer, R., Mulè, M. P., Rachmaninoff, N., Chen, J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114706 · Cited by 14
Lipsit, S., Wilkinson, J., Scruten, E., Facciuolo, A., Denomy, C., Griebel, P. J., KUSALIK, A. J., Plastow, G. S., & Napper, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68039-6 · Cited by 18
Kiecolt‐Glaser, J. K., Renna, M. E., Peng, J., Sheridan, J. F., Lustberg, M. B., Ramaswamy, B., Wesolowski, R., VanDeusen, J. B., Williams, N. O., Sardesai, S. D., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.019 · Cited by 18
Zusammensetzung und Wirkmechanismen von Adjuvanzien in zugelassenen viralen Impfstoffen
Wagner, R., & Hildt, E. (2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-019-02921-1 · Cited by 17
Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting influenza susceptibility
Wang, G., Lv, C., Liu, C., & Shen, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1003380 · Cited by 16
Routy, J., & Mehraj, V. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0164-9 · Cited by 14
“Hepatitis B vaccine To further elucidate the factors influencing CoP, the Sekaly group studied vaccine response in elderly participants following hepatitis B vaccination [3].”
BackgroundBig Data: Challenge and Opportunity for Translational and Industrial Research in Healthcare
Rossi, R. L., & Grifantini, R. (2018) · Frontiers in Digital Humanities · doi:10.3389/fdigh.2018.00013 · Cited by 18
“For instance, preexisting immunity, sex, or age related factors were shown to affect the response to hepatitis B and the influenza vaccine (Furman et al., 2014; Fourati et al., 2016).”
BackgroundCanzoni, M., Marignani, M., Sorgi, M. L., Begini, P., Biondo, M. I., Caporuscio, S., Colonna, V., Casa, F. D., Conigliaro, P., Marrese, C., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111792 · Cited by 13
“Actually, HBV infection markers were more likely observed in patients with Chronic Arthritis, who were also those presenting the highest levels of inflammation markers, a condition recently found to be predictive of low response to HB vaccination [20]; this suggests that this group of patients may also clear HBV less…”
BackgroundUsing the power of innate immunoprofiling to understand vaccine design, infection, and immunity
Connors, J. R., Cusimano, G. M., Mege, N. J., Woloszczuk, K., Konopka, E., Bell, M. R., Joyner, D., Marcy, J., Tardif, V., Kutzler, M. A., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2267295 · Cited by 14
“This has been demonstrated for several clinically approved vaccines such as the hepatitis B virus (HBV), 74 and influenza 75 vaccines.”
BackgroundMethodResultInfluentialSchramm, C. A., Moon, D., Peyton, L., Lima, N. S., Wake, C., Boswell, K. L., Henry, A. R., Laboune, F., Ambrozak, D. R., Darko, S. W., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43420-x · Cited by 13
Kuri-Cervantes, L., Fourati, S., Canderan, G., & Sékaly, R. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.06.010 · Cited by 13
“Systems vaccinology has been applied in recent years to identify correlates of protection for vaccines against yellow fever (YF-17D), influenza and hepatitis B [16 ,17,18].”
BackgroundSelf-citationAevermann, B. D., Shannon, C. P., Novotny, M. A., Ben-Othman, R., Cai, B., Zhang, Y., Ye, J. C., Kobor, M. S., Gladish, N., Lee, A. H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690470 · Cited by 13
Rappuoli, R., Siena, E., & Finco, O. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029256 · Cited by 13
“Novel immune cell–profiling technologies, such as polychromatic flow cytometry or mass cytometry (CyTOF), are enabling the integration of transcriptional signatures with phenotypic information (Fourati et al. 2016).”
BackgroundResultAn Inflammatory Clock Predicts Multi-morbidity, Immunosenescence and Cardiovascular Aging in HumansPreprint
Sayed, N., Gao, T., Tibshirani, R. J., Hastie, T. J., Cui, L., Kuznetsova, T., Rosenberg‐Hasson, Y., Ostan, R., Monti, D., Lehallier, B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/840363 · Cited by 12
“…showing that high levels of baseline inflammatory markers correlate with weaker responses to hepatitis B and herpes zoster vaccine formulations (Fourati et al., 2016; Thevaranjan et al., 2017); and with our previous longitudinal studies of aging also showing that chronic inflammation is, at…”
BackgroundResultImmunosenescence and susceptibility to respiratory viruses: a state-of-the-art review
Fragkou, P. C., Skevaki, C. L., Moschopoulos, C. D., Keske, Ş., Wozniak, H., Malézieux-Picard, A., Prendki, V., & Rello, J. (2026) · European Respiratory Review · doi:10.1183/16000617.0248-2025 · Cited by 14
“To predict immune response to vaccination, a systems biology approach to examine gene signatures and molecular pathways could be developed [123, 124].”
Effects of Aging on Metabolic Characteristics of Human B Cells
Frasca, D., Pallikkuth, S., & Pahwa, S. G. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002860 · Cited by 11
Metadata
- Authors
- Fourati, S., Cristescu, R., Loboda, A., Talla, A., Filali, A., Railkar, R., Schaeffer, A. K., Favre, D., Gagnon, D., Peretz, Y., Wang, I.-M., Beals, C. R., Casimiro, D. R., Carayannopoulos, L. N., & Sékaly, R.-P.
- Affiliations
- University Hospitals of Cleveland (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Caprion (Canada) (CA)
- Corresponding author
- Sékaly, Rafick-Pierre
- ORCID
- Venue
- Nature Communications
- Published
- 2016-01-08
- Volume
- 7
- Issue
- 1
- Pages
- 10369-10369
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4729923
- OpenAlex
- W2229921221
- Cited by
- 183
- References
- 46
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 23 · 2023: 19 · 2022: 28 · 2021: 24 · 2020: 20 · 2019: 11 · 2018: 16 · 2017: 12 · 2016: 3
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Foundation for the National Institutes of Health
- Case Western Reserve University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- hepatitis B vaccine, immunosenescence, older adults, B cell response, memory B cells, innate immune cells, red blood cell count, vaccine response prediction, cytokines
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, B-Lymphocytes, Erythrocyte Count, Female, Flow Cytometry, Hepatitis B Surface Antigens, Humans, Inflammation, Male, Middle Aged, Vaccination, Cohort Studies, Biomarkers, Hepatitis B Vaccines, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.